Researchers injected mice with human cancer cells and then tested the /*Trojan Horse*/ therapy. They say they have achieved 100 percent survival rate. Human clinical trials are set to begin in the coming months.
Reuters contributed to this report.
Report Typo |
Send Tip |
Get Alerts | Most Popular
Follow @abc7 on Twitter | Become a fan on Facebook